VIDEO: Apalutamide’s tolerability in prostate cancer patients

a day ago bySpecialist in Clinical Oncology, Hong Kong Sanatorium & Hospital, Honorary Clinical Associate Professor, Chinese University of Hong Kong
Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, discusses apalutamide’s tolerability in prostate cancer patients.

CP-516441
Disclaimer
This video is made possible through an unrestricted educational grant from the industry. The views expressed in this publication reflect the experience and opinions of the expert(s).